Nautilus Biotechnolgy, Inc. Common Stock

NAUTNASDAQ • USD
ThemeGenomics & Precision Med.›Precision Medicine Platforms
2.51 USD
↘ 0.11 (4.20%)AT CLOSE (11:59 AM EDT)
2.53
↗ 0.02 (0.80%)
POST MARKET (AS OF 07:03 PM EDT)
Post Market
AS OF 07:03 PM EDT
2.53
↗ 0.02 (0.80%)
🔴Market: CLOSED
Open?$2.59
High?$2.59
Low?$2.47
Prev. Close?$2.62
Volume?333.1K
Avg. Volume?336.6K
VWAP?$2.52
Rel. Volume?0.99x
Bid / Ask
Bid?$2.52 × 1.7K
Ask?$2.54 × 5.7K
Spread?$0.02
Midpoint?$2.53
Valuation & Ratios
Market Cap?319.0M
Shares Out?127.1M
Float?34.7M
Float %?27.4%
P/E Ratio?N/A
P/B Ratio?2.21
EPS?-$0.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.
Themes
Healthcare - Genomics & Precision Medicine›Precision Medicine PlatformsMedical Devices & HealthTech›Diagnostic Imaging & Equipment
Employees
130
Market Cap
319.0M
Industry
LABORATORY ANALYTICAL INSTRUMENTS
Website
www.nautilus.bio
Listed
2021-06-10
Address
2701 EASTLAKE AVE EAST
SEATTLE, WA 98102
Phone: 206-333-2001
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?11.85Strong
Quick Ratio?11.85Strong
Cash Ratio?1.75Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score
100/100
P/E?
N/A▾
P/B?
2.21CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
-4.9CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
-39.5%WEAK▾
ROA?
-32.1%WEAK▾
Cash Flow & Enterprise
FCF?$-51427000
Enterprise Value?$304.3M
Fundamentals ratios updated end of day
MarketsMoversWatchlist